Employees: 11-50
Total raised: $39.35M
Founded date: 2020
Funding Rounds 3
| Date | Series | Amount | Investors |
| 30.03.2022 | Series A | $27M | - |
| 22.04.2021 | Seed | $10M | - |
| 24.08.2020 | Seed | $2.35M | - |
Mentions in press and media 13
| Date | Title | Description |
| 18.12.2023 | RNAimmune Receives Investigational New Drug Application Clearance from U.S. FDA for mRNA-Based Respiratory Syncytial Virus Vaccine RV-1770 | GERMANTOWN, Md and GUANGZHOU, China, Dec. 18, 2023 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical com... |
| 28.04.2023 | RNAimmune Receives FDA Clearance of Investigational New Drug Application for Phase 1 Trial of RV-1730 COVID-19 Booster Vaccine | GERMANTOWN, Md. and GUANGZHOU, China, April 28, 2023 /PRNewswire/ -- RNAimmune, Inc. (the "Company" or "RNAimmune"), a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and va... |
| 07.02.2023 | RNAimmune mRNA Cancer Vaccine Program Accepted for Oral Presentation at the 2023 AACR Annual Meeting | HONG KONG, GERMANTOWN, Md., and SUZHOU, China, Feb. 7, 2023 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, and together with its subsidiaries, the "Group" or "Sirnaomics"), a leading bioph... |
| 30.03.2022 | RNAimmune Secures $27 Million Series A Round of Financing for Development of mRNA Therapeutics and Vaccines | GAITHERSBURG, Md., March 30, 2022 /PRNewswire/ -- RNAimmune, Inc. (the "Company" or "RNAimmune"), a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, announced t... |
| 22.04.2021 | RNAimmune Raises $10M in Seed Financing | RNAimmune, Inc., a Gaithersburg, MD-based biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, raised $10m in seed funding. Smooth River and Hong Kong Hongrun led the investment, with ... |
| 22.04.2021 | RNAimmune Raises $10M In Seed Financing | RNAimmune, Inc., a Gaithersburg, MD-based biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, raised $10m in seed funding. Smooth River and Hong Kong Hongrun led the investment, with ... |
| 22.04.2021 | RNAimmune Raises $10M In Seed Financing | RNAimmune, Inc., a Gaithersburg, MD-based biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, raised $10m in seed funding. Smooth River and Hong Kong Hongrun led the investment, with ... |
| 21.04.2021 | Sirnaomics' Spin-Off RNAimmune Secures $10 Million Seed Financing to Advance its mRNA-Based Vaccine and Therapeutic Development | |
| 21.04.2021 | Sirnaomics' Spin-Off RNAimmune Secures $10 Million Seed Financing | RNAimmune, Inc., a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, announced today execution of definitive agreements for a seed round financing of $10 million. RNAimmune is a spi... |
| 29.01.2021 | Meet the 20 most promising #dctech companies: RealLIST Startups 2021 | It’s a new year, and we’ve been publishing annual looks at the most promising local tech companies under our RealLIST Startups series for five years now. This is the list where we name 20 local startups that we think will make waves this ye... |
Show more